Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, tapentadol film-coated tablets (Palexia®) cannot be endorsed for use within NHS Wales for the relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics. |
||
|
||
Medicine details |
||
| Medicine name | tapentadol (Palexia®) | |
| Formulation | film-coated tablet | |
| Reference number | 771 | |
| Indication | For the relief of moderate to severe acute pain in adults, which can be adequately managed only with opioid analgesics. |
|
| Company | Grunenthal Ltd | |
| BNF chapter | Central nervous system | |
| Submission type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Ratification by Welsh Government | 11/10/2011 | |
| Date of issue | 14/10/2011 | |